Koers Stratec Biomedical AG Xetra
Aandelen
DE0007289001
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
||
- EUR | - |
26/04 | STRATEC BIOMEDICAL SYSTEMS AG : Berenberg herhaalt het Neutraal advies | ZD |
26/04 | STRATEC BIOMEDICAL SYSTEMS AG : Warburg Research is neutraal gestemd over het aandeel | ZD |
Omzet 2024 * | 276 mln. 295 mln. | Omzet 2025 * | 297 mln. 317 mln. | Marktkapitalisatie | 506 mln. 541 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 19 mln. 20,32 mln. | Nettowinst (verlies) 2025 * | 25 mln. 26,73 mln. | EV/omzet 2024 * | 2,33 x |
Nettoschuld 2024 * | 137 mln. 147 mln. | Nettoschuld 2025 * | 75,66 mln. 80,89 mln. | EV/omzet 2025 * | 1,96 x |
K/w-verhouding 2024 * |
25,4
x | K/w-verhouding 2025 * |
19,6
x | Werknemers | - |
Dividendrendement 2024 * |
2,31% | Dividendrendement 2025 * |
2,18% | Vrij verhandelbaar | 59,43% |
Recentste transcriptie over Stratec Biomedical AG
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Marcus Wolfinger
CEO | Chief Executive Officer | 56 | 01-03-98 |
Robert Siegle
DFI | Director of Finance/CFO | 56 | 01-05-98 |
Jan Keppeler
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank Hiller
BRD | Director/Board Member | 57 | 29-05-19 |
Georg Heni
CHM | Chairman | 66 | 20-05-22 |
Rolf Vornhagen
BRD | Director/Board Member | 70 | 21-07-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,07% | 219 mld. | |
+6,59% | 183 mld. | |
+11,26% | 133 mld. | |
+26,57% | 108 mld. | |
+0,65% | 63,06 mld. | |
+13,35% | 52,02 mld. | |
-0,62% | 48,2 mld. | |
-0,93% | 40,37 mld. | |
+11,54% | 39,35 mld. |